Cargando…
Platelet CD34 expression in a patient with a partial deletion of transcription factor subunit CBFB
Autores principales: | van Bergen, Maaike G.J.M., Saes, Joline L., Simons, Annet, Hebeda, Konnie M., Henskens, Yvonne M.C., Barteling, Wideke, Huys, Erik, Laros‐van Gorkom, Britta A.P., Schols, Saskia E.M., Preijers, Frank W., Jongmans, Marjolijn C.J., Jansen, Joop H., van der Reijden, Bert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317484/ https://www.ncbi.nlm.nih.gov/pubmed/32124467 http://dx.doi.org/10.1002/ajh.25770 |
Ejemplares similares
-
Pregnancy outcome in afibrinogenemia: Are we giving enough fibrinogen concentrate? A case series
por: Saes, Joline L., et al.
Publicado: (2020) -
Pharmacodynamic monitoring of factor VIII replacement therapy in hemophilia A: Combining thrombin and plasmin generation
por: Valke, Lars L.F.G., et al.
Publicado: (2020) -
Combining factor VIII levels and thrombin/plasmin generation: A population pharmacokinetic‐pharmacodynamic model for patients with haemophilia A
por: Bukkems, Laura H., et al.
Publicado: (2022) -
Molecular mechanisms of bleeding disorderassociated GFI1B(Q287*) mutation and its affected pathways in megakaryocytes and platelets
por: van Oorschot, Rinske, et al.
Publicado: (2019) -
Changed concepts and definitions of myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in the updated 2008 WHO classification
por: Hebeda, Konnie M., et al.
Publicado: (2009)